Arcturus is responsible for a surge in COVID case counts in some parts of the world, including India, where itchy or “sticky” eyes have been most frequently reported in children, along with ...

XBB.1.16 Arcturus symptoms According to Schaffner, there have been “a slew of anecdotal reports" from doctors that the XBB.1.16 variant may be causing a few distinct and unusual symptoms ...

Arcturus shared additional data from the ARCT-154 arm of its ongoing Phase 1/2 study in the U.S., Singapore, and South Africa evaluating a single 5-mcg booster dose of ARCT-154 given at least five ...

Arcturus’ commitment to the development of novel RNA therapeutics has led to collaborations with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson ...

Arcturus, also known as XBB.1.16, has also attracted attention after reports linking it to what has been a rare COVID-19 symptom: pink eye.

Arcturus, which is thought to be the most infectious and vaccine-resistant version of the virus yet, has already spread to 31 states, with California, New Jersey and New York emerging as hotspots.

XBB.1.16 Arcturus symptoms According to Schaffner, there have been “a slew of anecdotal reports" from doctors that the XBB.1.16 variant may be causing a few distinct and unusual symptoms ...

Arcturus Therapeutics Holdings Inc. ARCT is engaged in developing messenger RNA (mRNA) medicines and vaccines based on its innovative and enabling technologies. San Diego, CA-based Arcturus has ...

New COVID-19 strain Arcturus may cause pink eye, LA Department of Public Health warns By Jack Hobbs Published April 30, 2023, 12:24 p.m. ET ...

The new omicron variant XBB.1.16, better known as arcturus, is now responsible for about 14% of new Covid cases, per the latest data from the Centers for Disease Control and Prevention (CDC).

SAN DIEGO, August 05, 2024--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease ...